Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance
出版年份 2022 全文链接
标题
Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance
作者
关键词
-
出版物
Frontiers in Cellular and Infection Microbiology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-07-07
DOI
10.3389/fcimb.2022.926758
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Preventative treatment with Fluorothiazinon suppressed Acinetobacter baumannii-associated septicemia in mice
- (2022) Nataliya E. Bondareva et al. JOURNAL OF ANTIBIOTICS
- P. aeruginosa augments irradiation injury via 15-lipoxygenase–catalyzed generation of 15-HpETE-PE and induction of theft-ferroptosis
- (2022) Haider H. Dar et al. JCI Insight
- How to kill Pseudomonas —emerging therapies for a challenging pathogen
- (2021) Luke N. Yaeger et al. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
- The involvement of PacIRA system of Stenotrophomonas maltophilia in the uptake of Pseudomonas aeruginosa pyochelin and intraspecies competition for iron acquisition
- (2021) Sz-Yun Pan et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Type 3 secretion system of Pseudomonas aeruginosa
- (2021) Gertrudis Horna et al. MICROBIOLOGICAL RESEARCH
- Inhibition of Pseudomonas aeruginosa Alginate Synthesis by Ebselen Oxide and Its Analogues
- (2021) Soo-Kyoung Kim et al. ACS Infectious Diseases
- Evolution of Subfamily I.1 Lipases in Pseudomonas aeruginosa
- (2021) Zhenghong Zhang et al. CURRENT MICROBIOLOGY
- Type 3 secretion system as an anti-Pseudomonal target
- (2021) Gertrudis Horna et al. MICROBIAL PATHOGENESIS
- Interaction between the type 4 pili machinery and a diguanylate cyclase fine-tune c-di-GMP levels during early biofilm formation
- (2021) Shanice S. Webster et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Dual-Specificity Inhibitor Targets Polyphosphate Kinase 1 and 2 Enzymes To Attenuate Virulence of Pseudomonas aeruginosa
- (2021) Nolan Neville et al. mBio
- Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in Pseudomonas aeruginosa
- (2021) Douglas J. Fraser-Pitt et al. Frontiers in Cellular and Infection Microbiology
- An inside look at a biofilm: Pseudomonas aeruginosa flagella biotracking
- (2021) Eden Ozer et al. Science Advances
- Antipathogenic Compounds That Are Effective at Very Low Concentrations and Have Both Antibiofilm and Antivirulence Effects against Pseudomonas aeruginosa
- (2021) Hyeon-Ji Hwang et al. Microbiology Spectrum
- Substrate‐Inspired Fragment Merging and Growing Affords Efficacious LasB Inhibitors
- (2021) Cansu Kaya et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Bacterial phospholipases C with dual activity: phosphatidylcholinesterase and sphingomyelinase
- (2021) Laura Monturiol‐Gross et al. FEBS Open Bio
- Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections
- (2021) Luke L. Proctor et al. Antibiotics-Basel
- Iron acquisition in Pseudomonas aeruginosa by the siderophore pyoverdine: an intricate interacting network including periplasmic and membrane proteins
- (2020) Anne Bonneau et al. Scientific Reports
- Structural and dynamic insights revealing how lipase binding domain MD1 of Pseudomonas aeruginosa foldase affects lipase activation
- (2020) Aldino Viegas et al. Scientific Reports
- The Pseudomonas aeruginosa product pyochelin interferes with Trypanosoma cruzi infection and multiplication in vitro
- (2020) Gabriele Sass et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Inflammasome activation by Pseudomonas aeruginosa ’s ExlA pore‐forming toxin is detrimental for the host
- (2020) Stéphanie Bouillot et al. CELLULAR MICROBIOLOGY
- Approach to the treatment of patients with serious multidrug‐resistant Pseudomonas aeruginosa infections
- (2020) J Nicholas O’Donnell et al. PHARMACOTHERAPY
- Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa
- (2020) Chiara Rezzoagli et al. PLOS BIOLOGY
- Quorum Quenching: A Potential Target for Antipseudomonal Therapy
- (2020) Fatemeh Hemmati et al. Infection and Drug Resistance
- Identification of the fatty acid coenzyme‐A ligase FadD1 as an interacting partner of FptX in the Pseudomonas aeruginosa pyochelin pathway
- (2020) Béatrice Roche et al. FEBS LETTERS
- Pseudomonas aeruginosa Biofilms
- (2020) Minh Tam Tran Thi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Novel Pyoverdine Inhibitors Mitigate Pseudomonas aeruginosa Pathogenesis
- (2019) Daniel R. Kirienko et al. Frontiers in Microbiology
- Pseudomonas aeruginosa orchestrates twitching motility by sequential control of type IV pili movements
- (2019) Lorenzo Talà et al. Nature Microbiology
- Type IV pili: dynamics, biophysics and functional consequences
- (2019) Lisa Craig et al. NATURE REVIEWS MICROBIOLOGY
- Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition
- (2019) Osmel Fleitas Martínez et al. Frontiers in Cellular and Infection Microbiology
- High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant “high-risk clones” of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals
- (2019) Gertrudis Horna et al. Scientific Reports
- Tanshinones: First-in-Class Inhibitors of the Biogenesis of the Type 3 Secretion System Needle of Pseudomonas aeruginosa for Antibiotic Therapy
- (2019) Chao Feng et al. ACS Central Science
- Pseudomonas aeruginosa Lipoxygenase LoxA Contributes to Lung Infection by Altering the Host Immune Lipid Signaling
- (2019) Eric Morello et al. Frontiers in Microbiology
- Disarming Pseudomonas aeruginosa Virulence by the Inhibitory Action of 1,10-Phenanthroline-5,6-Dione-Based Compounds: Elastase B (LasB) as a Chemotherapeutic Target
- (2019) Anna Clara M. Galdino et al. Frontiers in Microbiology
- Pseudomonas aeruginosa Keratitis: Protease IV and PASP as Corneal Virulence Mediators
- (2019) Richard O’Callaghan et al. Microorganisms
- Overproduction of lipoxygenase from Pseudomonas aeruginosa in Escherichia coli by auto-induction expression and its application in triphenylmethane dyes degradation
- (2019) Jing Lu et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- The Membrane-Integrated Steric Chaperone Lif Facilitates Active Site Opening of Pseudomonas aeruginosa Lipase A
- (2019) Neha Verma et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Microbe Profile: Pseudomonas aeruginosa: opportunistic pathogen and lab rat
- (2019) Stephen P. Diggle et al. MICROBIOLOGY-SGM
- 674. Pre-Clinical and Phase I Safety Data for Anti-Pseudomonas aeruginosa Human Monoclonal Antibody AR-105
- (2019) Andreas Loos et al. Open Forum Infectious Diseases
- Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections
- (2019) Yu‐Xuan Ma et al. Advanced Science
- The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology
- (2019) Steven M. Huszczynski et al. Pathogens
- Specific oxygenation of plasma membrane phospholipids by Pseudomonas aeruginosa lipoxygenase induces structural and functional alterations in mammalian cells
- (2018) Maceler Aldrovandi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Anti-biofilm effect of novel thiazole acid analogs against Pseudomonas aeruginosa through IQS pathways
- (2018) Shengrong Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa
- (2018) R. Jain et al. Journal of Cystic Fibrosis
- Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa
- (2018) Ramadan Hassan et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Binding Mode Characterization and Early in Vivo Evaluation of Fragment-Like Thiols as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa
- (2018) Andreas M. Kany et al. ACS Infectious Diseases
- Pseudomonas aeruginosa Protease IV Exacerbates Pneumococcal Pneumonia and Systemic Disease
- (2018) Jessica L. Bradshaw et al. mSphere
- Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides
- (2018) Lydia C. Powell et al. npj Biofilms and Microbiomes
- Identification of FDA-approved drugs as antivirulence agents targeting the pqs quorum sensing system of Pseudomonas aeruginosa
- (2018) Francesca D'Angelo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults
- (2018) S.O. Ali et al. CLINICAL MICROBIOLOGY AND INFECTION
- Small Molecule Inhibitor of Type Three Secretion System Belonging to a Class 2,4-disubstituted-4H-[1,3,4]-thiadiazine-5-ones Improves Survival and Decreases Bacterial Loads in an Airway Pseudomonas aeruginosa Infection in Mice
- (2018) Anna B. Sheremet et al. Biomed Research International
- Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
- (2017) Seth W. Dickey et al. NATURE REVIEWS DRUG DISCOVERY
- Pseudomonas aeruginosa Pore-Forming Exolysin and Type IV Pili Cooperate To Induce Host Cell Lysis
- (2017) Pauline Basso et al. mBio
- The Type VI Secretion System: A Dynamic System for Bacterial Communication?
- (2017) Mathias Gallique et al. Frontiers in Microbiology
- OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model
- (2016) Wang Hengzhuang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- APseudomonas aeruginosa-secreted protease modulates host intrinsic immune responses, but how?
- (2016) Zhenyu Cheng BIOESSAYS
- Considerations and caveats in anti-virulence drug development
- (2016) Damien Maura et al. CURRENT OPINION IN MICROBIOLOGY
- Inhibition of the Injectisome and Flagellar Type III Secretion Systems by INP1855 ImpairsPseudomonas aeruginosaPathogenicity and Inflammasome Activation
- (2016) Ahalieyah Anantharajah et al. JOURNAL OF INFECTIOUS DISEASES
- Game of Trans-Kingdom Effectors
- (2016) Sophie Bleves TRENDS IN MICROBIOLOGY
- Cellular Effects of Pyocyanin, a Secreted Virulence Factor of Pseudomonas aeruginosa
- (2016) Susan Hall et al. Toxins
- Fitness Cost of Fluoroquinolone Resistance in Clinical Isolates of Pseudomonas aeruginosa Differs by Type III Secretion Genotype
- (2016) Melissa Agnello et al. Frontiers in Microbiology
- The LasB Elastase of Pseudomonas aeruginosa Acts in Concert with Alkaline Protease AprA To Prevent Flagellin-Mediated Immune Recognition
- (2015) Fiordiligie Casilag et al. INFECTION AND IMMUNITY
- Origin and Impact of Nitric Oxide in Pseudomonas aeruginosa Biofilms
- (2015) Francesca Cutruzzolà et al. JOURNAL OF BACTERIOLOGY
- Composition, function, and regulation of T6SS in Pseudomonas aeruginosa
- (2015) Lihua Chen et al. MICROBIOLOGICAL RESEARCH
- Type IV pili mechanochemically regulate virulence factors inPseudomonas aeruginosa
- (2015) Alexandre Persat et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pseudomonas Exotoxin A: optimized by evolution for effective killing
- (2015) Marta Michalska et al. Frontiers in Microbiology
- A Pseudomonas aeruginosa Type VI Secretion Phospholipase D Effector Targets Both Prokaryotic and Eukaryotic Cells
- (2014) Feng Jiang et al. Cell Host & Microbe
- A Type III Secretion Negative Clinical Strain of Pseudomonas aeruginosa Employs a Two-Partner Secreted Exolysin to Induce Hemorrhagic Pneumonia
- (2014) Sylvie Elsen et al. Cell Host & Microbe
- Pseudomonaschemotaxis
- (2014) Inmaculada Sampedro et al. FEMS MICROBIOLOGY REVIEWS
- Correlation of Pseudomonas aeruginosa Genotype With Antibiotic Susceptibility and Clinical Features of Induced Central Keratitis
- (2014) E. P. Shen et al. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
- Antibiotic resistance in Pseudomonas aeruginosa biofilms: Towards the development of novel anti-biofilm therapies
- (2014) Patrick K. Taylor et al. JOURNAL OF BIOTECHNOLOGY
- GtrS and GltR form a two-component system: the central role of 2-ketogluconate in the expression of exotoxin A and glucose catabolic enzymes inPseudomonas aeruginosa
- (2014) Abdelali Daddaoua et al. NUCLEIC ACIDS RESEARCH
- Blocking Phosphatidylcholine Utilization in Pseudomonas aeruginosa, via Mutagenesis of Fatty Acid, Glycerol and Choline Degradation Pathways, Confirms the Importance of This Nutrient Source In Vivo
- (2014) Zhenxin Sun et al. PLoS One
- A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
- (2014) A. DiGiandomenico et al. Science Translational Medicine
- Identification of Anti-virulence Compounds That Disrupt Quorum-Sensing Regulated Acute and Persistent Pathogenicity
- (2014) Melissa Starkey et al. PLoS Pathogens
- Interaction between extracellular lipase LipA and the polysaccharide alginate of Pseudomonas aeruginosa
- (2013) Petra Tielen et al. BMC MICROBIOLOGY
- Tit-for-Tat: Type VI Secretion System Counterattack during Bacterial Cell-Cell Interactions
- (2013) Marek Basler et al. CELL
- Biofilm infections, their resilience to therapy and innovative treatment strategies
- (2013) U. Römling et al. JOURNAL OF INTERNAL MEDICINE
- A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation
- (2013) C. T. O'Loughlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bacterial Quorum Sensing: Its Role in Virulence and Possibilities for Its Control
- (2013) S. T. Rutherford et al. Cold Spring Harbor Perspectives in Medicine
- Pseudomonas aeruginosa: new insights into pathogenesis and host defenses
- (2013) Shaan L. Gellatly et al. Pathogens and Disease
- Pseudomonas aeruginosaTwitching Motility: Type IV Pili in Action
- (2012) Lori L. Burrows Annual Review of Microbiology
- A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence
- (2012) Deepak Balasubramanian et al. NUCLEIC ACIDS RESEARCH
- Differentiation in Quinolone Resistance by Virulence Genotype in Pseudomonas aeruginosa
- (2012) Melissa Agnello et al. PLoS One
- Type II-dependent secretion of a Pseudomonas aeruginosa DING protein
- (2012) Geneviève Ball et al. RESEARCH IN MICROBIOLOGY
- Hemolytic Phospholipase C Inhibition Protects Lung Function duringPseudomonas aeruginosaInfection
- (2011) Matthew J. Wargo et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix
- (2011) Kelly M. Colvin et al. ENVIRONMENTAL MICROBIOLOGY
- Quorum quenching quandary: resistance to antivirulence compounds
- (2011) Toshinari Maeda et al. ISME Journal
- Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection
- (2011) T. Secher et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Type II Secretion System of Pseudomonas aeruginosa: In Vivo Evidence of a Significant Role in Death Due to Lung Infection
- (2011) Jeevan Jyot et al. JOURNAL OF INFECTIOUS DISEASES
- Type VI secretion delivers bacteriolytic effectors to target cells
- (2011) Alistair B. Russell et al. NATURE
- Active Starvation Responses Mediate Antibiotic Tolerance in Biofilms and Nutrient-Limited Bacteria
- (2011) D. Nguyen et al. SCIENCE
- Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria
- (2011) Hiromi Sato et al. Frontiers in Microbiology
- Pseudomonas Aeruginosa: Resistance to the Max
- (2011) Keith Poole Frontiers in Microbiology
- Biosynthesis of the Pseudomonas aeruginosa Extracellular Polysaccharides, Alginate, Pel, and Psl
- (2011) Michael J. Franklin et al. Frontiers in Microbiology
- Preclinical In Vitro and In Vivo Characterization of the Fully Human Monoclonal IgM Antibody KBPA101 Specific for Pseudomonas aeruginosa Serotype IATS-O11
- (2010) M. P. Horn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Iron uptake and metabolism in pseudomonads
- (2010) Pierre Cornelis APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- The type III secretion injectisome, a complex nanomachine for intracellular ‘toxin’ delivery
- (2010) Guy R. Cornelis BIOLOGICAL CHEMISTRY
- A Type VI Secretion System of Pseudomonas aeruginosa Targets a Toxin to Bacteria
- (2010) Rachel D. Hood et al. Cell Host & Microbe
- ThePseudomonas aeruginosapatatin-like protein PlpD is the archetype of a novel Type V secretion system
- (2010) Richard Salacha et al. ENVIRONMENTAL MICROBIOLOGY
- Lipase LipC affects motility, biofilm formation and rhamnolipid production in Pseudomonas aeruginosa
- (2010) Frank Rosenau et al. FEMS MICROBIOLOGY LETTERS
- Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients
- (2010) Gerd Döring INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Protein secretion systems in Pseudomonas aeruginosa: A wealth of pathogenic weapons
- (2010) Sophie Bleves et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles
- (2010) T. N. Ellis et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Extracellular enzymes affect biofilm formation of mucoid Pseudomonas aeruginosa
- (2010) P. Tielen et al. MICROBIOLOGY-SGM
- Anti-virulence strategies to combat bacteria-mediated disease
- (2010) David A. Rasko et al. NATURE REVIEWS DRUG DISCOVERY
- Pharmacokinetics and Safety Profile of the Human Anti-Pseudomonas aeruginosa Serotype O11 Immunoglobulin M Monoclonal Antibody KBPA-101 in Healthy Volunteers
- (2009) H. Lazar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies*
- (2009) Jeffrey L. Veesenmeyer et al. CRITICAL CARE MEDICINE
- Evaluation of Flagella and Flagellin of Pseudomonas aeruginosa as Vaccines
- (2009) V. L. Campodonico et al. INFECTION AND IMMUNITY
- The type III secretion system of Pseudomonas aeruginosa: infection by injection
- (2009) Alan R. Hauser NATURE REVIEWS MICROBIOLOGY
- Incidence of Pseudomonas aeruginosa Bacteremia: A Population-Based Study
- (2008) Majdi N. Al-Hasan et al. AMERICAN JOURNAL OF MEDICINE
- Roles of type IV pili, flagellum-mediated motility and extracellular DNA in the formation of mature multicellular structures inPseudomonas aeruginosabiofilms
- (2008) Kim B. Barken et al. ENVIRONMENTAL MICROBIOLOGY
- Biofilm-detached cells, a transition from a sessile to a planktonic phenotype: a comparative study of adhesion and physiological characteristics in Pseudomonas aeruginosa
- (2008) Cécile Rollet et al. FEMS MICROBIOLOGY LETTERS
- An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity
- (2008) M. Baer et al. INFECTION AND IMMUNITY
- Swarming of Pseudomonas aeruginosa Is a Complex Adaptation Leading to Increased Production of Virulence Factors and Antibiotic Resistance
- (2008) J. Overhage et al. JOURNAL OF BACTERIOLOGY
- Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
- (2008) Louis B. Rice JOURNAL OF INFECTIOUS DISEASES
- Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis
- (2008) M. H. Choy et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Impairment of Apoptotic Cell Engulfment by Pyocyanin, a Toxic Metabolite ofPseudomonas aeruginosa
- (2007) Stephen M. Bianchi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The biology and future prospects of antivirulence therapies
- (2007) Lynette Cegelski et al. NATURE REVIEWS MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search